Hybrid Quantum Systems Simulate 12,000-Atom Protein as Chemistry Work Shifts Toward Biomedical Use
Updated
Updated · Bits&Chips · May 11
Hybrid Quantum Systems Simulate 12,000-Atom Protein as Chemistry Work Shifts Toward Biomedical Use
1 articles · Updated · Bits&Chips · May 11
A hybrid quantum-classical workflow simulated protein systems with more than 12,000 atoms, marking the largest biologically relevant quantum chemistry calculation reported so far.
The result suggests useful chemistry work does not have to wait for fault-tolerant quantum machines, with quantum processors paired with classical supercomputers to handle parts of the workload.
A second recent project used quantum technology to improve the design of light-activated cancer drugs, showing the same push beyond proof-of-principle experiments.
Together, the studies point to a gradual move toward practical biomedical applications, even though quantum hardware still does not beat top classical supercomputers overall.
Are today's hybrid quantum gains a true breakthrough, or will classical computing advancements soon surpass them?
Now that we can simulate huge molecules, how soon will we see the first quantum-designed drugs in clinical trials?
With billions invested, what is the real business case for quantum computing before fault-tolerant machines arrive?
Quantum-Centric Supercomputing Achieves Record 12,635-Atom Protein Simulation: A New Era for Drug Discovery and Biomedicine
Overview
In May 2026, Cleveland Clinic, RIKEN, and IBM achieved a major milestone by using a quantum-centric supercomputing approach to simulate complex proteins. This breakthrough combined the power of up to 94 qubits with advanced classical supercomputers, enabling the largest heterogeneous quantum-classical electronic-structure calculation ever performed. The team successfully modeled protein–ligand chemistry, reaching a simulation size of over 12,000 atoms. This accomplishment marks a significant leap in quantum computing, moving from theory to real-world applications and opening new possibilities for drug discovery and biomedical research.